Dr. Reddy's Laboratories Limited, Fujifilm Venture By March To Foray Into Japanese Generics Market-DNA

DNA reported that Dr. Reddy's Laboratories Limited is likely to sign an agreement with image processing and photography technology company Fujifilm by the fiscal end for a foray into the Japanese generics market. Dr Reddy’s had announced the partnership in July. Fujifilm has an exclusive partnership with Dr Reddy’s in the generics business. Plans are afoot to set up a joint venture (JV) company, with Fujifilm owning a 51% stake and Dr Reddy’s the balance. The new company will develop, manufacture and promote generic drugs, utilising both Fujifilm’s advanced quality control technologies it has built up through its photo film business and Dr Reddy’s expertise in cost competitive production technologies for active pharmaceutical ingredients (APIs) and formulations gained over the years by supplying to markets globally.